| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 09.02.
| MERIDIAN BIOSCIENCE INC - 10-Q, Quarterly Report | | - | SEC Filings |
| 31.01.
| XFRA DIVIDEND INFORMATION - 01.02.2012 - 2 | | 109 | Xetra Newsboard |
| FOLGENDE WERTPAPIERE WERDEN AM 01.02.2012 EX DIVIDENDE GEHANDELT. THE EX-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 01.02.2012. INSTR EXCH ISIN INSTRUMENT NAME DIVIDEND AMOUNT 4OT XFRA US6780491071...
Mehr lesen zu:
XFRA DIVIDEND INFORMATION - 01.02.2012 - 2 | |
| 30.01.
| XFRA DIVIDEND INFORMATION - 01.02.2012 - 1 | | 114 | Xetra Newsboard |
| FOLGENDE WERTPAPIERE WERDEN AM 31.01.2012 CUM DIVIDENDE UND AM 01.02.2012 EX DIVIDENDE GEHANDELT. THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 31.01.2012. THE EX-DIVIDEND DAY WILL BE 01.02.2012....
Mehr lesen zu:
XFRA DIVIDEND INFORMATION - 01.02.2012 - 1 | |
| 30.01.
| RSI Alert For Top-Ranked Meridian Bioscience Inc. | | - | Forbes |
| 25.01.
| How the Wheels Came Off Meridian Bioscience's Bus | | - | Motley Fool |
| 25.01.
| Meridian Bioscience Reports First Quarter 2012 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2012 Guidance | | 21 | Business Wire |
| Meridian Bioscience, Inc. (NASDAQ: VIVO):
GENERAL HIGHLIGHTS
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:
...
Mehr lesen zu:
Meridian Bioscience Reports First Quarter 2012 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2012 Guidance | |
| 27.12.
| Meridian Bioscience Receives FDA Clearance For ImmunoCard C. difficile GDH Test | | - | Benzinga.com |
| 27.12.
| Meridian Bioscience (VIVO) Gets FDA Approval for ImmunoCard C. difficile GDH | | - | StreetInsider.com |
| 27.12.
| Meridian Bioscience Receives FDA Clearance For ImmunoCard® C. difficile GDH Test | | 41 | Business Wire |
| Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today
announced it has received FDA clearance for a new Clostridium
difficile assay, ImmunoCard®
C. difficile...
Mehr lesen zu:
Meridian Bioscience Receives FDA Clearance For ImmunoCard® C. difficile GDH Test | |
| 12.12.
| Meridian Bioscience (VIVO) Gets FDA Clearance for Illumigene Platform GBS Test | | - | StreetInsider.com |
| 12.12.
| Meridian Bioscience Receives FDA Clearance for New Molecular Test: illumigene® Group B Streptococcus | | 17 | Business Wire |
| Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today
announced that it has received FDA clearance for a new molecular
diagnostic test for Group B Streptococcus...
Mehr lesen zu:
Meridian Bioscience Receives FDA Clearance for New Molecular Test: illumigene® Group B Streptococcus | |
| 10.11.
| Meridian Bioscience Reports Fourth Quarter and Full-Year 2011 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2012 Guidance | | 35 | Business Wire |
| Meridian Bioscience, Inc. (NASDAQ: VIVO):
GENERAL HIGHLIGHTS
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:
...
Mehr lesen zu:
Meridian Bioscience Reports Fourth Quarter and Full-Year 2011 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2012 Guidance | |
| 02.09.
| Zacks Sell List Highlights: Royal Caribbean Cruises, Trina Solar, Meridian Bioscience and Patterson Companies | | 91 | PR Newswire |
| CHICAGO, Sept. 2, 2011 /PRNewswire/ -- Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List - Stocks to Sell Now. These stocks are currently...
Mehr lesen zu:
Zacks Sell List Highlights: Royal Caribbean Cruises, Trina Solar, Meridian Bioscience and Patterson Companies | |
| 25.08.
| Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal 2012 and Comments on Fiscal 2011 Guidance | | 33 | Business Wire |
| Meridian Bioscience, Inc. (NASDAQ: VIVO) today provided the financial
community with guidance regarding the Company's fiscal 2012 sales and
earnings estimates. Based on...
Mehr lesen zu:
Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal 2012 and Comments on Fiscal 2011 Guidance | |
| 23.08.
| Meridian Bioscience Establishes Direct Sales in Australia Through Bioline Australia | | 33 | Business Wire |
| Meridian Bioscience, Inc., (NASDAQ: VIVO) is pleased to announce the
commencement of a new, direct distribution arrangement in Australia for
the Meridian diagnostic products....
Mehr lesen zu:
Meridian Bioscience Establishes Direct Sales in Australia Through Bioline Australia | |
